| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |